New drug for alcohol addiction comes closer to reality
Advertisement
Washington D.C, Oct 15 : A team of researchers might be one step closer to finding an effective drug for alcohol dependence, bringing hope for the peope who are ready to recover from alcoholism.
In two separate studies, researchers at Karolinska Institutet and the Sahlgrenska Academy in Sweden show that the dopamine stabilizer OSU6162 can reduce the craving for alcohol in alcohol dependent people and normalises the level of dopamine in the brain reward system of rats that have consumed alcohol over a long period of time. However, thorough clinical studies are needed to determine if the OSU6162 also can help alcohol dependent people drink less alcohol.
The results of the studies are promising, but there is still a long way to go before they have a marketable drug, says co-author Pia Steensland, adding that the socioeconomic costs of alcohol are huge, not to mention the human suffering. It is inspiring to continue working.
Roughly a million Swedes over 15 years of age drink so much alcohol that they risk damaging their health and it is estimated that some 300,000 of these people are dependent. Despite the pressing need, there are only a few approved drugs for the treatment of alcohol dependence, but their effects vary from person to person and the prescriptions rates are low. Consequently the hunt for new, more efficacious drugs for alcohol dependence continues.
Researchers think that OSU6162 can reduce the alcohol craving in dependent people by returning the downregulated levels of dopamine in their brain reward system to normal, says Steensland.
The study is published in journal European Neuropsychopharmacology.
In two separate studies, researchers at Karolinska Institutet and the Sahlgrenska Academy in Sweden show that the dopamine stabilizer OSU6162 can reduce the craving for alcohol in alcohol dependent people and normalises the level of dopamine in the brain reward system of rats that have consumed alcohol over a long period of time. However, thorough clinical studies are needed to determine if the OSU6162 also can help alcohol dependent people drink less alcohol.
The results of the studies are promising, but there is still a long way to go before they have a marketable drug, says co-author Pia Steensland, adding that the socioeconomic costs of alcohol are huge, not to mention the human suffering. It is inspiring to continue working.
Roughly a million Swedes over 15 years of age drink so much alcohol that they risk damaging their health and it is estimated that some 300,000 of these people are dependent. Despite the pressing need, there are only a few approved drugs for the treatment of alcohol dependence, but their effects vary from person to person and the prescriptions rates are low. Consequently the hunt for new, more efficacious drugs for alcohol dependence continues.
Researchers think that OSU6162 can reduce the alcohol craving in dependent people by returning the downregulated levels of dopamine in their brain reward system to normal, says Steensland.
The study is published in journal European Neuropsychopharmacology.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.